Rochester, NY (PRWEB) January 29, 2014
The El Paso Times stated that 11 people in the southern region of Texas died suddenly due to complications associated with an influenza (flu) infection (1). The report went on to state that “The deaths involved six people between the ages of 31 and 65 years old. The others involved a young adult and four people who were older than 65… (and) … eight of the 11 cases tested positive for the H1N1 flu virus strain (1).” polyDNA recommends Gene-Eden-VIR to help the immune system target the latent flu virus. This natural product was clinically proven to reduce viral symptoms in a study that followed FDA guidelines.
El Paso city epidemiologist Fernando Gonzalez said “We know that H1N1 is severely affecting many of those who are infected with that particular strain, which is why flu prevention is so important (1).” Margaret Althoff-Olivas, spokeswoman for the University Medical Center agreed, noting that “Our health care team reports that this is the worst flu season in the region since the winter of 2008 to 2009 (1).”
Health authorities continue to recommend flu vaccination. Fernando Gonzalez said, "… we urge anyone who hasn't had a flu shot to get one and to practice good prevention measures (1).” However, there are multiple studies that show that the flu vaccine may not be enough to stop the flu virus.
For example, one study found that the flu vaccine against the most common strain in 2012 (H3N2) offered very little protection. In other words, it was not effective. As study authors wrote, “Overall… protection against influenza (H3N2) infection was low, with significant intraseasonal waning.” (See the European medical journal Eurosurveillance, from January 31, 2013) (2).
Another study showed that the effectiveness of the flu vaccine was low, and that a person’s immunity against the flu disappeared in a short amount of time. “These results suggest a low preventive effect of the 2011/12 seasonal influenza vaccine, and a decline in VE (vaccine effectiveness) with time since vaccination.” (See the European medical journal Eurosurveillance, also from January 31, 2013) (3).
polyDNA therefore suggests taking Gene-Eden-VIR, a natural remedy that was designed to target latent viruses.
A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced viral symptoms. Study authors wrote that, “Individuals… reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (4).” The post marketing study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (4).”
To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) El Paso flu-related deaths rise to 11. Published on January 23, 2014.
(2) Vaccine Effectiveness of 2011/12 Trivalent Seasonal Influenza Vaccine in Preventing Laboratory-Confirmed Influenza in Primary Care in the United Kingdom: Evidence of Waning Intra-Seasonal Protection. Published on January 31, 2013.
(3) Decline in Influenza Vaccine Effectiveness with Time After Vaccination, Navarre, Spain, Season 2011/12. Published on January 31, 2013.
(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.